13-76992000-G-C

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1

The ENST00000636183.2(CLN5):​c.-99G>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000465 in 1,601,892 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0020 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00031 ( 0 hom. )

Consequence

CLN5
ENST00000636183.2 5_prime_UTR

Scores

2
11

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:11

Conservation

PhyloP100: -2.40

Publications

2 publications found
Variant links:
Genes affected
CLN5 (HGNC:2076): (CLN5 intracellular trafficking protein) This gene is one of eight which have been associated with neuronal ceroid lipofuscinoses (NCL). Also referred to as Batten disease, NCL comprises a class of autosomal recessive, neurodegenerative disorders affecting children. The genes responsible likely encode proteins involved in the degradation of post-translationally modified proteins in lysosomes. The primary defect in NCL disorders is thought to be associated with lysosomal storage function.[provided by RefSeq, Oct 2008]
CLN5 Gene-Disease associations (from GenCC):
  • neuronal ceroid lipofuscinosis
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • neuronal ceroid lipofuscinosis 5
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Orphanet, Myriad Women’s Health

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0044178665).
BP6
Variant 13-76992000-G-C is Benign according to our data. Variant chr13-76992000-G-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 205123.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00197 (300/152318) while in subpopulation AFR AF = 0.00645 (268/41576). AF 95% confidence interval is 0.00581. There are 1 homozygotes in GnomAd4. There are 137 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000636183.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CLN5
NM_006493.4
MANE Select
c.-99G>C
upstream_gene
N/ANP_006484.2
CLN5
NM_001366624.2
c.-99G>C
upstream_gene
N/ANP_001353553.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CLN5
ENST00000636183.2
TSL:1
c.-99G>C
5_prime_UTR
Exon 1 of 4ENSP00000490181.2
CLN5
ENST00000377453.9
TSL:1 MANE Select
c.-99G>C
upstream_gene
N/AENSP00000366673.5
ENSG00000283208
ENST00000638147.2
TSL:5
c.-99G>C
upstream_gene
N/AENSP00000490953.2

Frequencies

GnomAD3 genomes
AF:
0.00196
AC:
299
AN:
152204
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00644
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000785
Gnomad ASJ
AF:
0.00173
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000132
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.000551
AC:
118
AN:
214040
AF XY:
0.000462
show subpopulations
Gnomad AFR exome
AF:
0.00507
Gnomad AMR exome
AF:
0.000576
Gnomad ASJ exome
AF:
0.00282
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000866
Gnomad OTH exome
AF:
0.000557
GnomAD4 exome
AF:
0.000307
AC:
445
AN:
1449574
Hom.:
0
Cov.:
34
AF XY:
0.000298
AC XY:
215
AN XY:
720728
show subpopulations
African (AFR)
AF:
0.00748
AC:
249
AN:
33278
American (AMR)
AF:
0.000547
AC:
24
AN:
43856
Ashkenazi Jewish (ASJ)
AF:
0.00275
AC:
71
AN:
25850
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39314
South Asian (SAS)
AF:
0.0000353
AC:
3
AN:
85084
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
48138
Middle Eastern (MID)
AF:
0.00183
AC:
10
AN:
5472
European-Non Finnish (NFE)
AF:
0.0000307
AC:
34
AN:
1108694
Other (OTH)
AF:
0.000902
AC:
54
AN:
59888
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
28
57
85
114
142
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00197
AC:
300
AN:
152318
Hom.:
1
Cov.:
32
AF XY:
0.00184
AC XY:
137
AN XY:
74478
show subpopulations
African (AFR)
AF:
0.00645
AC:
268
AN:
41576
American (AMR)
AF:
0.000784
AC:
12
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00173
AC:
6
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.000132
AC:
9
AN:
68028
Other (OTH)
AF:
0.00237
AC:
5
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.513
Heterozygous variant carriers
0
18
36
55
73
91
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000877
Hom.:
0
Bravo
AF:
0.00201
ESP6500AA
AF:
0.00285
AC:
11
ESP6500EA
AF:
0.000130
AC:
1
ExAC
AF:
0.000504
AC:
59

ClinVar

ClinVar submissions as Germline

Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not provided (4)
-
-
2
Neuronal ceroid lipofuscinosis (2)
-
-
2
Neuronal ceroid lipofuscinosis 5 (2)
-
-
2
not specified (2)
-
-
1
Inborn genetic diseases (1)
-
1
-
Neuronal Ceroid-Lipofuscinosis, Dominant/Recessive (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.56
T
BayesDel_noAF
Benign
-0.58
CADD
Benign
0.60
DANN
Uncertain
0.98
DEOGEN2
Benign
0.068
T
Eigen
Benign
-0.75
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.051
N
LIST_S2
Benign
0.30
T
M_CAP
Benign
0.0026
T
MetaRNN
Benign
0.0044
T
MetaSVM
Benign
-0.98
T
PhyloP100
-2.4
PrimateAI
Uncertain
0.59
T
MutPred
0.35
Loss of loop (P = 0.0112)
ClinPred
0.018
T
GERP RS
-1.9
PromoterAI
0.015
Neutral
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs202118652; hg19: chr13-77566135; API